Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study.
Nikitas J, Subramanian K, Gozal NB, Ricaurte-Fajardo A, Li E, Proudfoot JA, Davicioni E, Marciscano AE, Osborne JR, Barbieri CE, Armstrong WR, Smith CP, Valle LF, Steinberg ML, Boutros PC, Nickols NG, Rettig MB, Reiter R, Weiner AB, Calais J, Czernin J, Ross AE, Kim EH, Nagar H, Kishan AU. Nikitas J, et al. Among authors: nagar h. JCO Precis Oncol. 2024 Jul;8:e2400161. doi: 10.1200/PO.24.00161. JCO Precis Oncol. 2024. PMID: 39013135
Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer under Active Surveillance: Cancer Prostate Embolization, a Pilot Study.
Balasubramanian A, Nagar H, Barbieri CE, Tagawa ST, McClure TD. Balasubramanian A, et al. Among authors: nagar h. J Vasc Interv Radiol. 2021 Aug;32(8):1243-1244. doi: 10.1016/j.jvir.2021.05.021. Epub 2021 Jun 4. J Vasc Interv Radiol. 2021. PMID: 34091024 No abstract available.
68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study.
Martinez J, Subramanian K, Margolis D, O'Dwyer E, Osborne J, Jhanwar Y, Nagar H, Williams N, RoyChoudhury A, Madera G, Babich J, Huicochea Castellanos S. Martinez J, et al. Among authors: nagar h. Transl Oncol. 2022 Jan;15(1):101242. doi: 10.1016/j.tranon.2021.101242. Epub 2021 Oct 11. Transl Oncol. 2022. PMID: 34649151 Free PMC article.
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer.
Roy S, Zaorsky NG, Bagshaw HP, Berlin A, Tree A, Turner S, Koontz B, Nguyen P, Chen R, Dess RT, Jackson WC, Kishan AU, Stish B, Nagar H, Posadas E, Tran PT, Solanki A, Shore ND, Guo G, Ponsky L, Shoag JE, Morgans AK, Garcia JA, Showalter TN, Feng FY, Spratt DE. Roy S, et al. Among authors: nagar h. Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):278-289. doi: 10.1016/j.ijrobp.2021.12.005. Epub 2021 Dec 17. Int J Radiat Oncol Biol Phys. 2022. PMID: 34923058 Review.
179 results